Market Closed -
Other stock markets
|
After market 04:29:02 pm | |||
80.9 EUR | +0.31% | 81 | +0.12% |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Mar. 07 | Rovi explores sale of unit that makes drugs for third parties | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.39% | 4.52B | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Laboratorios Farmaceuticos Rovi, S.A. - BME
- News Laboratorios Farmaceuticos Rovi, S.A.
- Laboratorios Farmaceuticos Rovi S A : Rovi To Upgrade Spanish Facility To Boost Moderna's COVID-19 Vaccine Production